This established independent retail and compounding pharmacy operates from a strategically positioned free-standing facility in Montgomery County, Maryland, within the Washington DC metropolitan area. The business has maintained continuous operations since 2015, when current ownership developed a former bank site into a modern drive-through pharmacy adjacent to a medical office building on a high-traffic corridor with approximately 20,000 daily vehicle passages.

Operational Overview:
The pharmacy maintains a diversified revenue model with approximately 75% retail prescription services and 25% non-sterile compounding operations. The business serves an established customer base within a one-mile radius encompassing approximately 10,000 residents. Insurance contracting is maintained through EPIC with participation in Care Group pharmaceutical purchasing programs, supporting relationships with major PBM networks.

Compounding Capabilities:
The facility features purpose-built compounding infrastructure valued at approximately $218,000, including specialized ventilation systems with roof-mounted AON units supporting hazardous room requirements. Laboratory equipment portfolio includes dual hoods, MAZ mixer systems, capsulation equipment, and ointment mills. Established supplier relationships with PCCA, Spectrum Chemicals, Medisca, and Fagron ensure reliable ingredient sourcing.

Revenue Diversification:
The business operates multiple revenue streams including retail prescriptions, compounding services, and vaccination programs. Immunization services encompass influenza and COVID vaccinations billable to Medicare Part B, private insurance, and Maryland Medicaid. A substantial portion of the customer base includes cash-paying patients, particularly within Spanish-speaking demographics through established physician relationships.

Facility Assets:
The property includes custom front-end furnishings and shelving systems valued at approximately $45,000, supporting efficient retail operations. The drive-through configuration enhances customer convenience and operational efficiency.

Growth Potential:
Minimal marketing efforts to date present significant expansion opportunities. Current ownership expresses willingness to provide transition support and potential part-time consultation to facilitate business continuity and growth initiatives through enhanced physician relationships and targeted marketing strategies.

This opportunity represents an established pharmaceutical operation with proven infrastructure, diversified service offerings, and substantial growth potential in a high-visibility location within a densely populated market area.